Follicular Lymphoma Clinical Trials

A listing of Follicular Lymphoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35249

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study evaluating Ibrutinib and MEDI4736 for the treatment of Diffuse Large B-Cell Lymphoma or Follicular Lymphoma

Daphne Alabama 36526

A Phase 3 clinical study for patients with Follicular Lymphoma

Mobile Alabama 36607

A Phase 3 clinical study for patients with Follicular Lymphoma

Mobile Alabama 36607

A Phase 3 clinical study for patients with Follicular Lymphoma

View More ▼

Mobile Alabama 36608

A Phase 3 clinical study for patients with Follicular Lymphoma

Mobile Alabama 36608

A Phase 3 clinical study for patients with Follicular Lymphoma

Arizona

Glendale Arizona 85308

A Phase 3 clinical study for patients with Follicular Lymphoma

Phoenix Arizona 85016

A Phase 3 clinical study for patients with Follicular Lymphoma

Tucson Arizona 85710

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

California

City of Hope
Duarte California 91010

Phase 1/2 Study Of Intratumoral G100 With Or Without Pembrolizumab In Patients With Follicular Non-Hodgkin’s Lymphoma

View More ▼

Anaheim California 92801

A Phase 3 clinical study for patients with Follicular Lymphoma

Bakersfield California 93309

A clinical research study of IPI-145 (Duvelisib), Rituximab and Obinutuzumab for the treatment of CD20+ Follicular Lymphoma (CONTEMPO)

Burbank California 91505

A Phase 3 clinical study for patients with Follicular Lymphoma

Corona California 92879

A Phase 3 clinical study for patients with Follicular Lymphoma

Duarte California 91010

A clinical trial to evaluate treatments using JCAR017 single-dose schedule and JCAR017 2-dose schedule for patients with Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma or Mantle-cell Lymphoma

Duarte California 91010

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Duarte California 91010

Patients are needed to participate in a clinical research study evaluating Ibrutinib and MEDI4736 for the treatment of Diffuse Large B-Cell Lymphoma or Follicular Lymphoma

Fountain Valley California 92708

A Phase 3 clinical study for patients with Follicular Lymphoma

Fountain Valley California 92708

A Phase 3 clinical study for patients with Follicular Lymphoma

Fullerton California 92835

A clinical research study of IPI-145 (Duvelisib), Rituximab and Obinutuzumab for the treatment of CD20+ Follicular Lymphoma (CONTEMPO)

Glendale California 91206

A Phase 3 clinical study for patients with Follicular Lymphoma

Glendale California 91204

A Phase 3 clinical study for patients with Follicular Lymphoma

Huntington Beach California 92648

A Phase 3 clinical study for patients with Follicular Lymphoma

Irvine California 92618

A Phase 3 clinical study for patients with Follicular Lymphoma

Long Beach California 90813

A Phase 3 clinical study for patients with Follicular Lymphoma

Los Angeles California 90095

A clinical research study of IPI-145 (Duvelisib), Rituximab and Obinutuzumab for the treatment of CD20+ Follicular Lymphoma (CONTEMPO)

Los Angeles California 90017

A Phase 3 clinical study for patients with Follicular Lymphoma

Los Angeles California 90057

A Phase 3 clinical study for patients with Follicular Lymphoma

Los Angeles California 90017

A Phase 3 clinical study for patients with Follicular Lymphoma

Palm Springs California 92262

A Phase 3 clinical study for patients with Follicular Lymphoma

Palo Alto California 94304

A clinical research study of IPI-145 (Duvelisib), Rituximab and Obinutuzumab for the treatment of CD20+ Follicular Lymphoma (CONTEMPO)

Redondo Beach California 90277

A clinical research study of IPI-145 (Duvelisib), Rituximab and Obinutuzumab for the treatment of CD20+ Follicular Lymphoma (CONTEMPO)

Redondo Beach California 90277

A Phase 3 clinical study for patients with Follicular Lymphoma

Riverside California 92501

A Phase 3 clinical study for patients with Follicular Lymphoma

Sacramento California 95816

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

San Diego California 92123

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

San Francisco California 94115

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Signal Hill California 90755

A Phase 3 clinical study for patients with Follicular Lymphoma

Stanford California 94305

Patients are needed to participate in a clinical research study evaluating Ibrutinib and MEDI4736 for the treatment of Diffuse Large B-Cell Lymphoma or Follicular Lymphoma

Sylmar California 91342

A Phase 3 clinical study for patients with Follicular Lymphoma

Colorado

Aurora Colorado 80012

A Phase 3 clinical study for patients with Follicular Lymphoma

Boulder Colorado 80303

A Phase 3 clinical study for patients with Follicular Lymphoma

Boulder Colorado 80303

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Colorado Springs Colorado 8090

A Phase 3 clinical study for patients with Follicular Lymphoma

Denver Colorado 80220

A Phase 3 clinical study for patients with Follicular Lymphoma

View More ▼

Denver Colorado 80218

A Phase 3 clinical study for patients with Follicular Lymphoma

Denver Colorado 80218

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Lakewood Colorado 80228

A Phase 3 clinical study for patients with Follicular Lymphoma

Littleton Colorado 80120-4413

A Phase 3 clinical study for patients with Follicular Lymphoma